BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 18063544)

  • 1. Prostate cancer: a chronic illness.
    Doyle-Lindrud S
    Clin J Oncol Nurs; 2007 Dec; 11(6):857-61. PubMed ID: 18063544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caring for a patient with metastatic prostate cancer.
    Held-Warmkessel J
    Nursing; 2008 Jun; 38(6):52-6. PubMed ID: 18497662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choose wisely: therapeutic decisions and quality of life in patients with prostate cancer.
    O'Rourke ME
    Clin J Oncol Nurs; 2007 Jun; 11(3):401-8. PubMed ID: 17623624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer in older men.
    Calabrese DA
    Urol Nurs; 2004 Aug; 24(4):258-64, 268; quiz 269. PubMed ID: 15446376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinics in prostate cancer].
    Sugimura Y
    Rinsho Byori; 2004 Jul; 52(7):604-10. PubMed ID: 15344560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone ablation therapy: lightening the load for today's prostate cancer patient.
    Matthews PA
    Urol Nurs; 2007 Feb; 27 Suppl():3-11. PubMed ID: 17474637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachytherapy for prostate cancer: the patient's perspective.
    Ward-Smith P
    Urol Nurs; 2003 Jun; 23(3):213-7. PubMed ID: 12861739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
    Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
    J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L; Feldman-Stewart D; Brundage MD
    Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of patients with prostate cancer: the nurse's role.
    Turner B
    Nurs Stand; 2007 Jun 6-12; 21(39):48-56; quiz 58. PubMed ID: 17569378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA; Cowan JE; Smith JA; Carroll PR;
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer in the late 1990s: hormone refractory disease options.
    Moul JW; Lipo DR
    Urol Nurs; 1999 Jun; 19(2):125-31; quiz 132-3. PubMed ID: 10633763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncology today: new horizons. Prostate cancer.
    Greifzu SP
    RN; 2000 Jun; 63(6):26-31; quiz 32. PubMed ID: 10897747
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer treatment decisions: a focus group exploration.
    O'Rourke ME; Germino BB
    Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.
    Ross RW; Xie W; Regan MM; Pomerantz M; Nakabayashi M; Daskivich TJ; Sartor O; Taplin ME; Kantoff PW; Oh WK
    Cancer; 2008 Mar; 112(6):1247-53. PubMed ID: 18293426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of prostate cancer treatment: the good news.
    Denmeade SR; Isaacs JT
    Prostate; 2004 Feb; 58(3):211-24. PubMed ID: 14743459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate, cancer and lost patients].
    Nau JY
    Rev Med Suisse; 2012 May; 8(343):1186-7. PubMed ID: 22737953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.